Felipe Duran
CFO & Principal Accounting OfficerMr. Felipe Duran is Chief Financial Officer of iBio, Inc. from June 27, 2023 and serves as Principal Accounting Officer. He was Interim Chief Financial Officer of iBio, Inc. from February 13, 2023 to June 27, 2023. Prior to serving as the Interim Chief Financial Officer, Mr. Duran was Vice President of Financial Planning and Analysis from April 2021 to February 2023 at iBio, Inc., where he played a strategic role in the Company's forecasting, business planning, management reporting and business analytics activities. Previously, Mr. Duran served as the Executive Director (CFO), of Lupin Latin America, a subsidiary of Lupin Pharmaceuticals, from May 2016 to May 2021. Prior to joining Lupin Pharmaceuticals, he held numerous strategy positions at Teva Pharmaceuticals in both its growth markets and Latin America offices. Mr. Duran also worked as a Manager, FP&A for both Bupa and Noven Pharmaceuticals. Mr. Duran holds a B.A. in Finance and an M.B. A from the University of Miami.
Positions
- Company NameiBio, Inc.Stock CodeIBIOPositionCFO & Principal Accounting OfficerColleagues
- MBMartin B. BrennerCEO, Chief Scientific Officer & Director
- WDWilliam D. ClarkIndependent Chairman
- MBMarc BanjakChief Legal Officer & Corporate Secretary
- MCMolly CarrChief Medical Officer
- AKAlexandra KropotovaIndependent Director
- GLGary L. SenderIndependent Director
- DADavid A. ArkowitzIndependent Director
